Cargando…
TRAF7-targeted HOXA5 acts as a tumor suppressor in prostate cancer progression and stemness via transcriptionally activating SPRY2 and regulating MEK/ERK signaling
Homeobox A5 (HOXA5), a homeodomain transcription factor, is considered a tumor suppressor in cancer progression; however, its function in prostate cancer (PCa) remains unclear. This study focused on the relevance of HOXA5 in PCa progression. We identified the downregulation of HOXA5 in PCa tissues b...
Autores principales: | Ye, Jianfeng, Liu, Wangmin, Yu, Xueyang, Wu, Lina, Chen, Zhengjie, Yu, Yufei, Wang, Jianfeng, Bai, Song, Zhang, Mo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579307/ https://www.ncbi.nlm.nih.gov/pubmed/37845209 http://dx.doi.org/10.1038/s41420-023-01675-9 |
Ejemplares similares
-
SPRY4 promotes adipogenic differentiation of human mesenchymal stem cells through the MEK–ERK1/2 signaling pathway
por: Li, Na, et al.
Publicado: (2022) -
A Combined CRISP3 and SPINK1 Prognostic Grade in EPS-Urine and Establishment of Models to Predict Prognosis of Patients With Prostate Cancer
por: Chen, Lizhu, et al.
Publicado: (2022) -
Comprehensive Landscape of HOXA2, HOXA9, and HOXA10 as Potential Biomarkers for Predicting Progression and Prognosis in Prostate Cancer
por: Song, Yan-ping, et al.
Publicado: (2022) -
HAVCR1 Affects the MEK/ERK Pathway in Gastric Adenocarcinomas and Influences Tumor Progression and Patient Outcome
por: Xue, Ji, et al.
Publicado: (2019) -
RTK/ERK Pathway under Natural Selection Associated with Prostate Cancer
por: Chen, Yang, et al.
Publicado: (2013)